MRI substudy
PRImus-AD is a Phase II clinical trial investigating the efficacy and safety of an innovative drug in patients with mild cognitive impairment or mild Alzheimer's dementia.
Buyer
PRInnovation GmbH
Value
Not provided
Published
7 Aug 2026
Closes
Not provided
Procurement details
Source
TED (EU)
Country
Germany (DE)
Procurement method
Selective
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
73000000
Research and development services and related consultancy services
85148000
Medical analysis services
Lots
Lot LOT-0001 MRI substudy
Value not provided
PRImus-AD is a Phase II clinical trial investigating the efficacy and safety of an innovative drug in patients with mild cognitive impairment or mild Alzheimer's dementia. The study is randomised, double-blind, and placebo-controlled with three parallel study arms (two verum arms and one placebo arm). The aim of the clinical trial is to examine the effects o...
Delivery: anyw-eea · Anywhere in the European Economic Area
Documents
Unlock document linkTED notice 550167-2026
7 Aug 2026
Award notice · Web page
Contains information from TED (Tenders Electronic Daily), © European Union, reused under CC BY 4.0.